Loading...
Loading...
Contributors:
Dataset URI:
017ad463-bdbf-4107-b84d-5b8a3214c666The purpose of this study was to compare the safety and efficacy of ABT-493/ABT-530 to the combination of sofosbuvir (SOF) and daclatasvir (DCV) in adults with genotype 3 (GT3) chronic hepatitis C virus (HCV) infection.
Keyword(s):
ABT-493/ABT-530; Chronic Hepatitis C; Daclatasvir; Genotype 3 Hepatitis C Virus; Glecaprevir (ABT-493).
MeSH Term(s):
Grants and Funding:
Associated Publication(s):
No Associated Publication Data Available
Supplementary Data:
No Supplementary Data Available
Related Dataset(s):
The National Library of Medicine (NLM) provides information about biomedical datasets. Inclusion on an NLM Web page does not imply endorsement of, or agreement with, the contents by NLM or the National Institutes of Health. Learn more: NLM Web Policies (nih.gov)